First in human study finds novel immune cell therapy is safe and effective in advanced lymphoma

In a first-in-human study, researchers at The University of Texas MD Anderson Cancer Center observed strong responses and early signs of antitumor activity in patients with difficult-to-treat ...
NBC Los Angeles

SoCal doctors successfully perform world's first in-human bladder transplant

A cancer survivor from West Covina was the recipient of the world's first in-human bladder transplant this month, thanks to a pair of Los Angeles doctors. Surgeons from Keck Medicine of USC and UCLA ...
News Medical

World's first-in-human bladder transplant marks milestone in urologic surgery

Surgeons from Keck Medicine of USC and UCLA Health have performed the world's first-in-human bladder transplant. The surgery was successfully completed at Ronald Reagan UCLA Medical Center on May 4, ...
sciencex

First-in-human trial for regenerative cell therapy for sensorineural hearing loss approved

Rinri Therapeutics, a world leading spinout company from the University of Sheffield dedicated to transforming sensorineural hearing loss (SNHL) with regenerative cell therapy, has received approval ...
ascopubs.org

First-in-human study of AWT020, a bifunctional anti-PD-1/IL-2 fusion protein, in patients with advanced cancer.

A first-in-human phase 1 clinical trial of INI-4001, a novel TLR7/8 agonist, in patients with advanced solid tumors. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract ...
Benzinga.com

EXCLUSIVE: Vivani Medical Announces First Implant In Early-Stage Human Study Of GLP-1 Implant For Obesity

On Thursday, Vivani Medical, Inc. (NASDAQ:VANI) announced the administration of its first GLP-1 (exenatide, NPM-115) implant in the LIBERATE-1 trial in Australia. Vivani's lead program, NPM-115, ...